79
55
Growth Score 79 in past quarter
-5 pts
Heat Score 55 in past quarter
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
921552
DeCODE Genetics is a biopharmaceutical company that develops and offers diagnostic tests for variants in genes.
Unnur Thorsteinsdottir: Vice President of Research
Hákon Guðbjartsson: Vice President of Informatics
About the Company
DeCODE Genetics is a biopharmaceutical company that develops and offers diagnostic tests for variants in genes.
DeCODE was established to identify human genes associated with common diseases using population studies, and apply the knowledge gained to guide the development of candidate drugs. The company has discovered key genetic risk factors
for many common diseases ranging from cardiovascular disease to cancer.
DeCODE Genetics was founded in 1996 and is based in Reykjavik, Iceland.


